Ageno, Walter http://orcid.org/0000-0002-1922-8879
Casella, Ivan B.
Chee, Kok Han
Schellong, Sebastian
Schulman, Sam
Singer, Daniel E.
Desch, Marc
Tang, Wenbo
Voccia, Isabelle
Zint, Kristina
Goldhaber, Samuel Z.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study
https://doi.org/10.1007/s11239-020-02239-9
Funding for this research was provided by:
Boehringer Ingelheim
Università degli Studi dell'Insubria
Article History
First Online: 26 August 2020
Compliance with ethical standards
:
: Dr. Ageno has participated in advisory boards for Bayer, Portola, Aspen, Sanofi, Daiichi Sankyo, Boehringer Ingelheim, and has received travel or research support from Bayer, Portola, Aspen, Janssen, Sanofi, Daiichi Sankyo, Bristol-Myers Squibb, Pfizer, and Boehringer Ingelheim. Dr. Casella has received speaker and/or consultancy fees from Boehringer Ingelheim, Bayer, Daiichi Sankyo, Pfizer, and Amgen. Dr. Chee has received speaker fees from Boehringer Ingelheim, Bristol-Myers Squibb, and Pfizer. Dr. Schellong has received speaker fees from Bayer HealthCare, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Sanofi, and LEO Pharma. He has received consultancy fees from Bayer HealthCare, Boehringer Ingelheim, Daiichi Sankyo, GlaxoSmithKline, and Sanofi. Dr. Schulman has received honoraria from Alnylam, Boehringer Ingelheim, Bayer HealthCare, Daiichi Sankyo, Pfizer, and Sanofi, and research support from Boehringer Ingelheim and Octapharma. Dr. Singer has received honoraria from Boehringer Ingelheim, Bristol-Myers Squibb, Merck, Johnson & Johnson, and Pfizer, and research support from Boehringer Ingelheim and Bristol-Myers Squibb. Dr. Desch, Dr. Tang, Dr. Voccia, and Dr. Zint are employees of Boehringer Ingelheim. Dr. Goldhaber has received research support from Boehringer Ingelheim, Bristol-Myers Squibb, Boston Scientific BTG, Daiichi Sankyo, Janssen, and the US National Heart Lung and Blood Institute. He is a consultant for Bayer and Boehringer Ingelheim.
: The study was carried out in compliance with the protocol and the principles laid down in the Declaration of Helsinki. In addition, the applicable sections of the guidelines for Good Clinical Practice, Good Epidemiological Practice, and Good Pharmacoepidemiology Practices, and local regulations were followed.
: Patients (or their legal representative) provided written informed consent before study entrance, in accordance with local regulations. No study procedures or data recording were performed unless a patient had consented to participate in the study or a waiver had been obtained in accordance with local regulations.